PRELUDE CAPITAL MANAGEMENT, LLC - AQUESTIVE THERAPEUTICS INC ownership

AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 96 filers reported holding AQUESTIVE THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.78 and the average weighting 1.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of AQUESTIVE THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$229,814
+117.6%
88,390
+256.5%
0.02%
+166.7%
Q1 2024$105,631
+10463.1%
24,796
+12236.3%
0.01%
Q4 2018$1,0002010.00%
Other shareholders
AQUESTIVE THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Bratton Capital Management, L.P. 9,810,958$8,849,484100.00%
Vahanian & Associates Financial Planning Inc. 678,258$611,8572.00%
Latash Investments, LLC 243,134$219,3310.18%
Bracebridge Capital, LLC 428,571$386,6140.04%
D.B. Root & Company, LLC 12,500$11,2760.01%
Schonfeld Strategic Advisors LLC 506,600$457,0040.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 142,956$128,9610.00%
IFP Advisors, Inc 6,500$1040.00%
Financial Advocates Investment Management 32,000$28,8670.00%
Richard W. Paul & Associates, LLC 1,423$1,2840.00%
View complete list of AQUESTIVE THERAPEUTICS INC shareholders